The aim of this study was to investigate the effects of different general anaesthesia techniques on immune responses in patients undergoing surgery for tongue cancer. Sixty American Society of Anesthesiologists physical status 1 or 2 patients undergoing elective reconstructive surgery for tongue cancer were randomised to three groups. Group 1 received propofol induction and maintenance (TIVA), group 2 received propofol induction and sevoflurane maintenance (MIXED) and group 3 received sevoflurane induction and maintenance (SEVO). All patients received an infusion of remifentanil. Blood samples were obtained at eight time-points: 30 minutes before induction (T 0 ); one hour (T 1 ), three hours (T 2 ) and five hours (T 3 ) after induction; at the end of the operation (T 4 ); and 24 hours (T 5 ), 48 hours (T 6 ) and 72 hours (T 7 ) after operation. The T lymphocyte subsets (including CD3 + cells, CD3 + CD4 + cells and CD3 + CD8 + cells) and CD4 + /CD8 + ratio, natural killer cells and B lymphocytes were analysed by flow cytometry. All immunological indicators except CD3 + CD8 + cells were significantly decreased in all groups at T 1~T5 compared to T 0 (P <0.05). The percentages of CD3 + cells, CD3 + / CD4 + cells and natural killer cells, and the CD4 + /CD8 + ratios were significantly lower in the MIXED groups and SEVO groups but not the TIVA group at T 6 as compared with T 0 (P <0.05). There were minor but statistically significant differences in the percentages of CD3 + cells, CD3 + CD4 + cells and natural killer cells, and the CD4 + / CD8 + ratios between the SEVO group and the TIVA group at T 2~T6 (P <0.05). These findings suggest that propofol has slightly less effect on cellular immune responses than sevoflurane.
Surgical excision is one of the mainstays of treatment for tongue cancer. However, perioperative immunosuppression has been implicated in the development of postoperative septic complications and tumour metastasis 1 . General anaesthesia is considered to not only suppress surgical stress, but also to affect the immune function directly by altering the number and activity of immune cells 2 . It is reported also that some anaesthetics increase susceptibility to tumour spread, apparently by suppressing natural killer (NK) cell activity 3 , although different anaesthetic techniques and anaesthetic agents used in anaesthesia have shown different effects on immunity 4, 5 . To date, there are few published clinical studies designed to specifically investigate the effects of different general anaesthetic techniques on immune function in patients with oral malignant tumours undergoing major reconstructive procedures.
The aim of this randomised controlled study was to investigate the immune responses of patients undergoing radical operation and immediate tongue reconstruction with radial forearm free flap for tongue cancer under different types of general anaesthesia.
METHODS
The study was approved by the institutional ethics committee of the School pants before the trial. Patients classified as American Society of Anesthesiologists physical status 1 to 2 and aged 40 to 70 who had tongue cancer requiring reconstructive surgery were recruited. All the patients were scheduled for elective radical operation and immediate tongue reconstruction with radial forearm free flap under general anaesthesia. None had a history of endocrine, immune or circulatory system diseases. Other exclusion criteria included recent or concurrent chemotherapy, a requirement for perioperative blood transfusion or perioperative treatment with immunomodulatory agents. Patients who developed major surgical complications including infection were also excluded from our study. Sixty patients were recruited and were randomly allocated to three groups using a computer-generated randomisation list.
All patients were premedicated with phenobarbital 0.1 g and phencyclidine 0.5 mg intramuscularly 30 minutes before anaesthesia. After entering the operating room, the right subclavian vein was cannulated for central venous pressure monitoring and the radial artery was cannulated for invasive blood pressure monitoring. The electrocardiogram, SpO 2 , end-tidal carbon dioxide (P ET CO 2 ), cerebral state index and rectal temperature were also continuously monitored during the operation. In the propofol induction and maintenance (TIVA) group, anaesthesia was induced with propofol 2.0 to 2.5 mg/kg (Lot number 1006221, Xi'an Libang Pharmaceutical Co., Ltd, Shanxi, China) and remifentanil 1 to 2 μg/kg, and maintained with propofol 4 to 6 mg/kg/hour and remifentanil 0.2 to 0.3 μg/ kg/minute. The propofol induction and sevoflurane maintenance (MIXED) group received the same induction protocol as the TIVA group, followed by intravenous infusion of remifentanil 0.2 to 0.3 μg/kg/ minute and inhalation of 2 to 3% sevoflurane (Lot number 9615, Maruishi Pharmaceutical Co., Ltd, Osaka, Japan); the sevoflurane was substituted by an intravenous infusion of propofol 4 to 6 mg/kg/hour one hour before the end of surgery. The sevoflurane induction and maintenance (SEVO) group was induced with inhalation of 8% sevoflurane, with fresh gas flow 5 l/minute, remifentanil 1 to 2 μg/kg, and maintained with inhalation of 2 to 3% sevoflurane and intravenous infusion of remifentanil 0.2 to 0.3 μg/kg/minute. In all patients the depth of anaesthesia was monitored by cerebral state index and the concentration of sevoflurane or infusion rate of propofol adjusted to keep the cerebral state index between 40 and 60. Cisatracurium besylate 0.15 mg/kg was used for muscle relaxation in all groups. Thirty minutes before the end of surgery, sufentanil 0.1 μg/kg was administered as an intravenous bolus in every patient. All patients received patient-controlled intravenous analgesia for postoperative pain therapy.
Processing of blood samples and measurement of immune cells
Two millilitres of peripheral venous blood was obtained and added into anticoagulant test tubes (EDTAk 2 ) at eight time-points: 30 minutes before induction of anaesthesia (T 0 ); one hour (T 1 ), three hours (T 2 ) and five hours (T 3 ) after induction of anaesthesia; at the end of the operation (T 4 ); and 24 hours (T 5 ), 48 hours (T 6 ) and 72 hours (T 7 ) after operation. One hundred microlitres of anticoagulant blood sample was added into two separate tubes, incubated with 2 μl of fluorescent antibody CD3FITC/ CD8PE/CD45PerCP/CD4APC in tube 1, and 2 μl of fluorescent antibody CD3FITC/CD16+56PE/ CD45PerCP/CD19APC (Becton, Dickinson and Company, Franklin Lakes, NJ, USA) in tube 2. After 20 minutes at room temperature in the dark, 2 ml of 1:10 diluted fluorescence-activated cell sorting haemolysin was added. After a further ten minutes the mixture was centrifuged for five minutes and the supernatant was removed. Two millilitres of buffer as phosphate-buffered saline was then added, and centrifugation continued for five minutes before the supernatant was again removed. Lastly, 500 μl of phosphate-buffered saline suspension was added. Percentages of T lymphocyte subsets (CD3 + , CD3 + CD4 + , CD3 + CD8 + ), NK cells (CD3 -CD16 + 56 + ) and B lymphocytes (CD3 -CD19 + ) were analysed by flow cytometry (Becton, Dickinson and Company), which was calibrated by fluorescent microspheres of four colours before analysis. Data were collected and analysed by the computer program CellQuest Pro ™ (Becton, Dickinson and Company). Photofluorograms of FSC/SSC, SSC/CD45 and SSC/CD3 were established; the fluorescent cells in the photofluorogram were distributed appropriately by adjusting the voltage threshold of FSC, SSC and FL, and by using fluorescent compensation. Then the lymphocyte population was marked as R1 from the photofluorogram of SSC/CD45, and the T lymphocyte population was marked as R2 from the photofluorogram of SSC/CD3. The scatter diagrams of CD3 + cells, CD3 + CD4 + cells, CD3 + CD8 + cells, CD3 -CD16 + 56 + cells and CD3 -CD19 + cells were established and were set to display the cells as either R1 or R2. Cross Gate was set on lymphocytes, and 10,000 cells were analysed to determine the percentages of CD3 + cells, CD3 + CD4 + cells, CD3 + CD8 + cells, CD3 -CD16 + 56 + cells and CD3 -CD19 + cells. 
Statistics
According to the differences of percentages of NK cells between groups from our preliminary experiment, we considered a 20% difference between groups as clinically important, and using Chinese High Intellectualized Statistical Software, with a type-I error of 5% and a power of 80%, we needed 18 patients in each group. Anticipating a 10% dropout rate, we recruited a minimal sample size of 20 per group (60 in total). Data are expressed as mean ± standard deviation or number. Differences in age, weight, height, dose of remifentanil, duration of Table 2 Percentages of CD3 + 
cells, CD3 + CD4 + cells and CD3 + CD8 + cells and CD4 + /CD8 + ratio at different time-points
Group CD3 + (%) 
P=0.007
Data are expressed as mean ± standard deviation. TIVA=propofol induction and maintenance, MIXED=propofol induction and sevoflurane maintenance, SEVO=sevoflurane induction and maintenance, T 0 =30 minutes before induction of anaesthesia, T 1 =one hour after induction of anaesthesia, T 2 =three hours after induction of anaesthesia, T 3 =five hours after induction of anaesthesia, T 4 =the end of operation, T 5 =24 hours after operation, T 6 =48 hours after operation, T 7 =72 hours after operation. In comparison with T 0 , # P <0.05. In comparison with the TIVA group, ▼ P <0.05. In comparison with the MIXED group, ▀ P <0.05.
surgery and blood loss were compared using analysis of variance. Differences in sex, American Society of Anesthesiologists physical status and stage of tumour were compared using chi-square tests. A repeatedmeasures general linear model with a Huynh-Feldt correction for sphericity was employed to compare the differences in percentages of immune cells across different time-points in the same group. One-way analysis of variance was used for comparisons of percentages of immune cells between groups. Post hoc comparisons were performed with a Bonferroni correction to the significance level. Statistical significance was accepted at P <0.05. The statistical software SPSS 11.5 (SPSS Inc., Chicago, IL, USA) was used for all data analyses.
RESULTS
This study was carried out at the School and Hospital of Stomatology of Wuhan University and conducted according to the Declaration of Helsinki between May 2013 and August 2013.
Sixty of 70 eligible patients were finally included in this randomised study. Another four patients (one from the TIVA group, two from the MIXED group and one from the SEVO group) were excluded due to perioperative blood transfusion or postoperative infection. Thus, we were left with 19 patients in the TIVA group, 18 patients in the MIXED group and 19 patients in the SEVO group.
Patient demographics were similar in the three groups. No significant differences were found concerning stage of tumour, dose of remifentanil, duration of surgery or blood loss (P >0.05).
There were no significant differences in percentages of CD3 + or CD3 + CD4 + cells, CD4 + CD8 + ratios, or percentages of NK cells or B lymphocytes between the three groups before anaesthesia induction (P >0.05) ( Table 2, 3 
and 4).
Percentages of CD3 + and CD3 + CD4 + cells, and CD4 + /CD8 + ratios were significantly decreased at T 1-5 in all groups and also at T 6 in the MIXED group and the SEVO group as compared with the baseline value at T 0 , and were significantly lower at T 2-6 in the SEVO group than in the TIVA group (CD4 + /CD8 + ratio: 0.9±0.6 versus 1.1±0.6 at T 2 , 0.8±0.6 versus 1.2±0.5 at T 3 , 0.7±0.6 versus 1.1±0.8 at T 4 , 0.7±0.5 versus 1.1±0.8 at T 5 , 0.8±0.6 versus 1.5±1.0 at T 6 , respectively, for the SEVO group and TIVA group, P <0.05). Percentages of CD3 + CD4 + cells and CD4 + / CD8 + ratios were also significantly lower at T 2-3 in the MIXED group than in the TIVA group and significantly higher at T 4-5 in the MIXED group than in the SEVO group (P <0.05). There were no significant differences in the percentages of CD3 + CD8 + cells among the three groups (P >0.05) ( Table 2 ). Actual P values are given in the tables.
Percentages of NK cells were significantly decreased at T 1-5 in all groups and also at T 6 in the MIXED group and the SEVO group as compared with the baseline value at T 0 (MIXED group, 13.8±6.9% at T 6 versus 21.9±9.3% at T 0 , P=0.024; SEVO group, 10.8±6.7% at T 6 versus 23.1±6.7% at T 0 , P=0.007) and were significantly higher at T 4-5 in the MIXED group than in the SEVO group (12.8±6.9% versus 9.8±5.5%, respectively, for the MIXED group and SEVO group at T 4 , P=0.044; 14.3±7.6% versus 11.2±7.0%, respectively, for the MIXED group and SEVO group at T 5 , P=0.041) and significantly lower at T 2-6 in the SEVO group than in the TIVA group 
P=0.008
Data are expressed as mean ± standard deviation. NK=natural killer, TIVA=propofol induction and maintenance, MIXED=propofol induction and sevoflurane maintenance, SEVO=sevoflurane induction and maintenance, T 0 =30 minutes before induction of anaesthesia, T 1 =one hour after induction of anaesthesia, T 2 =three hours after induction of anaesthesia, T 3 =five hours after induction of anaesthesia, T 4 =the end of operation, T 5 =24 hours after operation, T 6 =48 hours after operation, T 7 =72 hours after operation.
In comparison with T 0 , # P <0.05. In comparison with the TIVA group, ▼ P <0.05. In comparison with the MIXED group, ▀ P <0.05.
(10.9±5.6% versus 15.7±5.9% at T 2 , 11.3±6.7% versus 16.1±5.8% at T 3 , 9.8±5.5% versus 15.4±5.6% at T 4 , 11.2±7.0% versus 15.1±5.3% at T 5 , 10.8±6.7% versus 22.3±7.4% at T 6 , respectively, for the SEVO group and TIVA group, P <0.05) ( Table 3) .
Percentages of B lymphocytes at T 1-5 were significantly lower than those at T 0 in the three groups (P <0.05), but there were no statistically significant differences in the percentages of B lymphocytes between the three groups at the same time-points (P >0.05) ( Table 4 ).
DISCUSSION
We conducted this randomised study to investigate the effects of three general anaesthesia methods on immune responses in patients undergoing surgery for tongue cancer. Our results showed that propofol induction and maintenance had slightly less impact on cellular immune responses than propofol induction with sevoflurane maintenance or sevoflurane induction and maintenance, when given with an infusion of remifentanil.
Tongue cancer is the one of the main types of oral malignant tumours. Radical operation and immediate tongue reconstruction is the common treatment for patients suffering from tongue cancer. Perioperative stress induced by surgery, hypothermia, hyperglycaemia, blood transfusion and postoperative pain possibly contributes to immunosuppression. The main cause is presumably related to the effects on the immune system or activation of the hypothalamicpituitary-adrenal axis and the sympathetic nervous system 6, 7 . Even without surgery, some anaesthetics also have direct suppressive effects on cellular and humoral immune function by affecting the number and functions of immunocompetent cells and inflammatory mediator gene expression and secretion. Particularly in cancer patients, immunosuppression after surgery accelerates the development of residual cancer cells and promotes the establishment of new metastases 8 .
Cell-mediated immunity is closely related to anti-tumour and neoplasm metastasis surveillance; improving perioperative cellular immune status and preventing excessive surgical stress responses contributes to attenuation of immunosuppression and resistance to metastasis 9 . In this study, all patients were treated by the same surgical team and received the same analgesic drugs for postoperative pain control to ensure the comparability of the indicators of immune function.
T lymphocytes are very important in cellular immunity. T cells (CD3 + ) comprise Th cells (CD4 + ) and Ts/Tc cells (CD8 + ); CD4 + T cells produce IFN-γ and IL-2, which favour cell-mediated immune responses; CD8 + T cells recognise and kill tumour cells and virus-infected cells. The CD4 + /CD8 + ratio has a positive association with cellular immune function; the reduction of the ratio implies the downregulation of cellular immune function. Changes of these cells mentioned above influence the whole immune system. Our results have shown that CD3 + cells, CD3 + CD4 + cells and CD4 + /CD8 + ratio were significantly decreased from T 1 to T 5 in all groups and were significantly decreased in the MIXED group and the SEVO group at T 6 compared with the baseline values ( Table 2) , which indicated that suppression of cell-mediated immunity occurred in all groups after anaesthesia. These data indicate that induction and maintenance of anaesthesia with propofol may be associated with less impairment of cellular immunity in patients with tongue cancer than the use of techniques involving the use of sevoflurane. Data are expressed as mean ± standard deviation. TIVA=propofol induction and maintenance, MIXED=propofol induction and sevoflurane maintenance, SEVO=sevoflurane induction and maintenance, T 0 =30 minutes before induction of anaesthesia, T 1 =one hour after induction of anaesthesia, T 2 =three hours after induction of anaesthesia, T 3 =five hours after induction of anaesthesia, T 4 =the end of operation, T 5 =24 hours after operation, T 6 =48 hours after operation, T 7 =72 hours after operation. In comparison with T 0 , # P <0.05.
Our findings concur with those of Kitamura et al 10 , who found a significant difference in lymphocyte count after anaesthesia between a sevoflurane group and a propofol group; the results of their study supported the ability of propofol to avoid the relative lymphopenia associated with the use of sevoflurane.
Humoral immunity is mediated by B lymphocytes, which produce antibodies. The reduction of percentages of B lymphocytes is possibly associated with inadequate antibodies and suppression of humoral immune function. In our study, the percentages of B lymphocytes decreased after anaesthesia in all three groups, but there were no significant differences between the three groups ( Table 4 ); this suggests that the three general anaesthetic techniques we used have similar effects of suppression on B lymphocytes.
NK cells are mainly involved in non-specific immunity and the function of NK cells is anti-tumour, anti-viral infection and immune regulation; activated NK cells can synthesise and secrete various cytokines such as IFN-γ, modulate immune function or directly kill the target cells. The number and function of NK cells are closely related to lymph node metastasis and distant metastasis, especially in patients with oral squamous cell carcinoma 11 . Furthermore, the decrease in the number or activity of NK cells can also lead to the survival of tiny tumour thrombi released free from the surgical field. This study found different degrees of decrease of percentages of NK cells after anaesthesia in the three groups; the percentages of NK cells in the TIVA group were significantly higher and recovered earlier than those in the SEVO group (Table 3 ). The percentages of NK cells were not significantly different between the MIXED group and the TIVA group from T 1 to T 5 , but recovered later in the MIXED group (T 6 ) compared to the TIVA group, P=0.023. This suggests that the avoidance of sevoflurane in the TIVA group resulted in less inhibition of NK cells.
Our results showed that there were some differences among the three groups in T lymphocytes and NK cells, but not in B lymphocytes. This suggests that there were no significant differences related to humoral immunity among the three groups we tested. Nevertheless, further research is still needed to find the exact mechanism of the immunosuppressive effects of anaesthetic agents.
As we have mentioned previously, most research involving anaesthesia and immunity focuses on the difference between general anaesthesia and epidural anaesthesia; there are few studies designed specifically to investigate the effects of different general anaesthetic techniques on immune function in patients with major tumours. Our study showed an interesting result: that the TIVA group has less change in cellular immune responses than the other two groups. However, we did not measure tumour recurrence and cannot comment on whether the differences we have observed will affect tumour recurrence rate in this group of patients. Some animal studies have described different influences on NK cell activity between propofol and inhalational anaesthetics. Melamed et al 3 found that propofol has little effect on the NK cell activity and tumour metastasis. Another study found that propofol may suppress PGE 2 synthesis and upregulate NK cell IFN-γ production, which promotes anti-tumour function 12 . Consequently, further studies involving the activity of immune cells are needed to determine which general anaesthesia method is the preferred choice for patients undergoing radical operation and immediate reconstruction such as tongue reconstruction with radial forearm free flap for tongue cancer.
CONCLUSIONS
Our results demonstrated that an anaesthetic technique using propofol for induction and maintenance has less effect on cellular immune responses in tongue cancer patients undergoing radical operation and immediate tongue reconstruction with radial forearm free flap than techniques involving the use of sevoflurane.
